Charles River Laboratories International, Inc. (CRL) closed at $333.39 on November 19, 2026, rising 0.36% over the prior 24-hour period. The move came as the contract research organization maintained a market capitalization of $15.92 billion.
Despite the daily gain, the stock has slipped 2.70% over the past seven days, suggesting some near-term consolidation after a period of stronger upward momentum.
Over the trailing 30 days, CRL has advanced 11.14%, reflecting a notably firmer trend on the longer time horizon. That monthly performance stands in contrast to the more subdued action seen over the shorter weekly window.
The divergence between the weekly decline and the 30-day gain points to a stock that has largely held on to recent advances even as short-term volatility creates modest headwinds.



